PREVENTIVE AND REHABILITATIVE MANAGEMENT OF ACUTE CORONARY SYNDROMES (NSTEMI, STEMI, PCI)

Similar documents
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

2012 Core Measures. Acute Myocardial Infarction (AMI)

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Subject: Outpatient Phase Ii Cardiac Rehab Individualized Treatment Plan And Exercise Prescription

Cardiac Rehabilitation after Primary Coronary Intervention CONTRA

This information explains the advice about the care and treatment of people with stable angina that is set out in NICE clinical guideline 126.

Acute Myocardial Infarction

Coronary Artery Disease

Cardiac Rehabilitation. Questions and Answers Information for Patients

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

Unstable angina and NSTEMI

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Cardiology. Cardiac Rehabilitation

The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager

Cardiac Rehabilitation Should be Paid in Korea?

Clinical guideline Published: 23 July 2011 nice.org.uk/guidance/cg126

Acute Coronary Syndrome- The Role of the ACS Clinic in Providing Best Practice Care

Preventive Cardiology

Ischaemic Heart Disease

The importance of follow-up after a cardiac event: CARDIAC REHABILITATION. Dr. Guy Letcher

Heart Disease. Signs and Symptoms

A multicenter tobacco cessation program in acute coronary syndrome

Clinical Practice Guideline

YOUR GUIDE TO. Understanding Your Angina Diagnosis and Treatment

Smoking Cessation Self-Management Plan and Care Plan

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

What is a myocardial infarction and how do we treat it? Paul Das Consultant Cardiologist North Wales Cardiac Centre Glan Clwyd Hospital

5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.

Smokefree Wiltshire. Information leaflet. Planning to quit? Find the right support for you.

Patients First. Acute Coronary Syndrome (ACS): Discharge Guidelines. If you have any questions or concerns, please ask your doctor or nurse.

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

PRESENTED BY BECKY BLAAUW OCT 2011

Practice-Level Executive Summary Report

Quality Payment Program: Cardiology Specialty Measure Set

CAMBRIDGESHIRE & PETERBOROUGH STOP SMOKING SERVICE S. Stop Smoking Pharmacological Products Guidance

1973: No-smoking sections introduced. 1990: No-smoking on all U.S. domestic flights

WHAT IS ATHEROSCLEROSIS?

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Course: Exercise and Aging for Special Populations

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Your heart attack procedure explained

2017 MSSP Clinical Quality Measures

Quality Payment Program: Cardiology Specialty Measure Set

Reducing risk in heart disease

Coronary Artery Disease Clinical Practice Guidelines

NHS QIS National Measurement of Audit Acute Coronary Syndrome

the high CVD risk smoker

Intermittent claudication exercise programme

A Guide to Help You Reduce and Stop Using Tobacco

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

Cardiovascular Disease Risk Factors:

Associate Professor Gerry Devlin

A new model for prescribing varenicline

Smoking It s never too late to quit

Guide to Cardiology Care at Scripps

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

APPENDIX F: CASE REPORT FORM

Cardiac Rehabilitation Exercise Programs Diabetic Management & Weight Loss Exercise Programs

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

Controversies in Cardiac Pharmacology

On my way through success!

SMART STEPS towards a tobacco-free life

Heart Disease (Coronary Artery Disease)

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

Medicines Management Optimisation Achieving your 5 a day post-mi Medication WORKSHOP

all about your heart...

The life after myocardial infarction: a long quiet river?

Smoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014


Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Smoke-free Hospitals. Linda A. Thomas, MS University of Michigan Health System Tobacco Consultation Service

Smoking and CVD. .what role for the Cardiologist? Dr Sandeep Gupta, MD, FRCP

Best Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree

Value of cardiac rehabilitation Prof. Dr. L Vanhees

Care Facilitation Quality Improvement Report

Examples of what to say when intervening with smoking clients. Do you smoke cigarettes or tobacco at all, or have you ever smoked regularly?

Patient Navigator Program: Focus MI Diplomat Hospital Metrics

Returning to fitness after a coronary stent procedure

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Physician Orders ADULT: Acute MI/Acute Coronary Syndrome Adult Plan

Long-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA

Advice to patients having an angioplasty

Rexall Ready-2-Quit. Continuous Care with Rexall

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Challenging clinical cases in cardiac rehabilitation: one size fits all? - women -

Control Your Risk Factors

4. Which survey program does your facility use to get your program designated by the state?

Cardiology Pharmacist. Melanie Madorsky, PharmD, BCPS TSHP Annual Meeting April 7, 2018

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

Chapter # 4 Angina. Know what to do if you feel angina

Clinical Considerations of High Intensity Interval Training (HIIT)

Dr Joan Leighton. Professor Gerry Devlin. 14:00-14:55 WS #106: Whats Topical in Cardiology 15:05-16:00 WS #116: Whats Topical in Cardiology (Repeated)


Using Stop Smoking Medicines

NEW JERSEY 2011 HOSPITAL PERFORMANCE REPORT TECHNICAL REPORT: METHODOLOGY RECOMMENDED CARE (PROCESS OF CARE) MEASURES

SECTION 17: NICOTINE REPLACEMENT. Formulary and Prescribing Guidelines

Transcription:

PREVENTIVE AND REHABILITATIVE MANAGEMENT OF ACUTE CORONARY SYNDROMES (NSTEMI, STEMI, PCI) Dato Dr. Balachandran Kandasamy Institut Jantung Negara 12 th November 2016

KEY MESSAGES 1. Initiate a long-term management plan for all patients with acute coronary syndromes (ACS) 2. Consider guideline-recommended medicines for all patients with ACS 3. Identify risk factors and refer all patients with ACS to secondary prevention programs 4. Communicate management plan to the patient, carers and the community healthcare providers

INITIATE A LONG-TERM MANAGEMENT PLAN FOR ALL PATIENTS WITH ACUTE CORONARY SYNDROMES Patients with ACS are at high risk of further cardiovascular events and death. For long-term management a medicines management plan, a chest pain action plan and a comprehensive cardiovascular risk reduction program are recommended. Communicate this plan to the patient and/or carer and their community healthcare providers.

INITIATE A LONG-TERM MANAGEMENT PLAN FOR ALL PATIENTS WITH ACUTE CORONARY SYNDROMES i. Medicines management plan ii. Chest pain action plan iii. Identify risk factors and refer to secondary prevention programs

i. Medicines Management Plan Consider starting guideline-recommended medicines in hospital before discharge. Provide all patients with a written medicines management plan which includes: a list of all medicines the dose and plan for any required dose titration intended duration of therapy the purpose and potential benefits of therapy potential adverse effects of each medicines schedule for follow-up and monitoring access to consumer medicine information.

INITIATE A LONG-TERM MANAGEMENT PLAN FOR ALL PATIENTS WITH ACUTE CORONARY SYNDROMES Communicate the management plan to patients and all those involved in care

ii. Identify Risk Factors And Refer To Secondary Prevention Programs Discuss the warning signs of a heart attack and an immediate plan of action, including the use of short-acting nitrates and the importance of dialling 000 if pain is not relieved. Each patient should receive a written chest pain action plan which includes: warning signs of a heart attack when and how to take the short-acting nitrate self-administration of aspirin, unless contraindicated instructions to call an ambulance if chest pain or discomfort lasts longer than 10 minutes additional instructions for patients who live in rural and remote locations

iii. Identify Risk Factors And Refer To Secondary Prevention Programs Actively refer to, and encourage attendance at, secondary prevention and cardiac rehabilitation programs. Provide education and set goals on lifestyle factors, including advice on smoking cessation where appropriate. Assess for depression and level of social support.

CONSIDER GUIDELINE-RECOMMENDED MEDICINES FOR ALL PATIENTS WITH ACS The combination of antiplatelet agents, a beta blocker, a statin and an angiotensin-converting enzyme (ACE) inhibitor is recommended for most patients, unless contraindicated. All four drug classes have been proven to reduce subsequent cardiac events and death. Individualise therapy according to known comorbidities, risk of adverse effects and clinical judgement. If the guideline-recommended therapy is not indicated for an individual, document this and the reason(s) why in the patient s medical record and long-term management plan.

IDENTIFY RISK FACTORS AND REFER ALL PATIENTS WITH ACS TO SECONDARY PREVENTION PROGRAMS Provide patients with a self-management plan before discharge, as patients and their families/carers are focused on promoting health and are more receptive to medical interventions immediately after an acute event. The plan should include advice on lifestyle changes that will reduce the risk of further cardiac events (including quitting smoking, good nutrition, moderating alcohol intake, regular physical activity and weight management), as appropriate. All patients should have access to, and be actively referred to, comprehensive secondary prevention and cardiac rehabilitation programs.

Refer All Patients to Their Closest Available Cardiac Rehabilitation Program Cardiac rehabilitation is a proven effective intervention. Attendance at cardiac rehabilitation outpatient programs reduces risk of further cardiac events. Cardiac rehabilitation, including advice about physical activity, improves individual health outcomes. Patients who participate in cardiac rehabilitation programs can improve physical activity, weight loss, smoking cessation, blood lipid levels and blood pressure control.

PRINCIPAL GOAL: CARDIAC REHABILITATION To lessen the risk of future coronary events, control symptoms arising from coronary disease and to return the patient to optimal or previous functional status Patient population predominantly confined to post MI, bypass graft, angioplasty & stable angina but must also be made available to heart failure patients. M.A CALDWELL & K. DRACUP, JOURNAL OF CARDIOPULMONARY REHABILITATION 2001

THE FOUR PHASES OF CARDIAC REHABILITATION Phase I Before discharge from hospital Phase II Early post-discharge period Phase III 4-6 weeks after an acute cardiac event Phase IV Long term maintenance of changed behaviour

PHYSIOTHERAPY IN IJN Inpatients & Outpatients Acute Care Cardiac Rehabilitation Programme I & II Ward Gym Patient Referral Exercise Programme

OTHER BENEFICIAL EFFECTS OF CARDIAC REHABILITATION FOR PATIENTS WITH CHD Improves Control of Dyslipidemia in secondary prevention B.L.,Verges et al Journal of Cardiopulmonary Rehabilitation, 1998 Weight loss intervention P.D., Savage et al Journal of Cardiopulmonary Rehabilitation, 2002 Post Myocardial infarction or CABG J. Redfern, Journal of Physiotherapy, 2011 Stable Chronic Heart Failure- can achieve significant improvement in functional capacity from a low intensity exercise training program. R. Belardinelli et al J Am Coll Cardiol, 1995 Exercise training improves exercise tolerance and LV function in patients with Dilated Cardiomyopathy K.Q., Stolen et al J Am Coll Cardiol, 2003

WHO Definition of Cardiac Rehabilitation The Sum of Activities required to ensure the patients, the best possible physical, mental and social conditions, so that they may (by their own efforts), resume and maintain as normal a place as possible in the community F.J.Brannon et al:cardiopulmonary rehabilitation: Basic Theory and Application 2 nd Ed, pg.148(1993)

CARDIAC REHABILITATION PHASE I Inpatient recovery program (ICU/ WARDS/ GYM) Post MI start 2-4 days after hospitalized Post surgery start 1-2 days after surgery Lasts for 2-3 weeks Intensive medical supervision Low intensity exercise (1.5-2.5 METS) 60% - 70% of MHR Exercise done daily- shoulder and arm exercises, gentle trunk exercises, ambulating short distances, gym & a flight of stairs without adverse symptoms

CARDIAC REHABILITATION PHASE II (IJN) Out patient convalescence program Starts within 2-3 weeks of discharge Lasts for 3 months Referred by physician and medically supervised Light to moderate exercise (2-5 METS) 65% - 75% of MHR 3 times per week 14/11/2016 24

PHYSIOTHERAPY & REHABILITATION DEPT., IJN, CRP PHASE II 1. Strengthening Exercises Assessment 5. Stretching and Cool down Circuit Training 2. Endurance Exercise (stationary bike or treadmill) Re-assessment 4. Exercise tolerance (walking for 6 mins) 3. Exercise Tolerance( step board) Patient Education 14/11/2016 25

Warm up/cool down CRP PHASE II -IJN - A gradual and progressive warm-up of 10 to 15 mins. incorporating mobility and stretching *Strenuous exertion without previous warm up produces Ischaemic ST segment changes and arrhythmias & reduction of left Ventricular ejection fraction, even In healthy individuals. (BACR, 1995 pg. 84) 14/11/2016 26

EXERCISE IN CARDIAC REHABILITATION Exercise, the cornerstone of CR esp. Phase II & III. Prescribe with the same precision as any medication. The ex. dose is the combination of intensity, frequency and duration of physical activity. Sufficient to produce a conditioning, but not enough to provoke complication. Aimed at enhancing cardiovascular fitness, strength, endurance and flexibility.

PATIENT EDUCATION (CRP I & II) One to one home counseling OR Group Education

CR EFFECTIVENESS IS DETERMINED BY A MULTIDISCIPLINARY APPROACH Cardiothoracic Surgeon Cardiologist Psychologist Physiotherapist/Exercise Physiologist Nurses/ Cardiac Nurse Dietician Pharmacist Diabetic Counselor Quit Smoking Counselor Patient and family

Provide Smoking-cessation Advice And Support To All Patients Who Smoke Smoking is one of the most significant risk factors for cardiovascular disease, including myocardial infarction (MI). Stopping smoking is associated with a substantial reduction in risk of allcause mortality among patients with coronary heart disease. Quitting smoking reduces the likelihood of a repeat cardiac event and the chances of developing other forms of cardiovascular disease. There is a rapid reduction in the risk of coronary heart disease within one year of quitting smoking. Brief educational interventions of 3 5 minutes have been shown to increase quitting rates compared with no intervention.

CATEGORY OF CLIENTS: QUIT SMOKING CLINIC IJN Referral case Referred by IJN Doctors ( in patient/outpatient) referral form doctor required cardiac Rehab Nurse will see patient and conduct counselling Self referred Patient call IJN for appointment slot will be given to client will be seen in clinic for counselling New referral - Outpatient / in patient ( We will see on the same day )

WHY IS SMOKING HARMFUL TO THE CARDIOVASCULAR SYSTEM? Increased tendency for vasoconstriction Increases level of bad cholesterol ie. LDL Reduces level of good cholesterol ie. HDL Reduces beneficial effects of medications eg. Statins, Aspirin

IMMEDIATE BENEFITS OF QUITTING Duration Of Abstinence Bonus 20 mins Lowers blood pressure & heart rate 8-12 hours Carbon monoxide & nicotine levels lowered by 50% 24 hours Oxygen levels normalize & immediate risks of heart attacks 48 hours Sense of smell & taste improves Nicotine disappears from body 2 weeks Circulation improves & lung function increase by 30% 4 weeks Nicotine withdrawal symptoms disappear

CONT.. The Right Way of Quitting Fix a date, be confident and look forward Always be positive and get support Fight your urge to smoke or use nicotine replacement therapy Drink lots of water to flush chemical Exercise > 5 minutes (stretching )or exercise Wash faces & keep hand wet Take shower more frequent Do chew gum with sugar free or vitamin C Avoid caffeine drink change to fruit juice Stop thinking about cigarette, divert to other things Distract yourself from situations which encourages smoking Do pray

TREATMENT AVAILABLE (PHARMACOLOGIC APPROACH) Non nicotine treatment (Non - NRT) in IJN 1.Champix tablet (varenicline) Nicotine treatment (NRT) buy from other companies 1.Nicorette tablet 2.Nicotine patch 3.Nicotin gum If patient request for NRT, send prescription slip to retail pharmacy, purchase and call patient.

CONT.. Choosing the right pharmacologic agent Patient preference Patient s previous experience with medication, either positive or negative Ease of administration Compliance Health care professional s familiarity with medications

CONT... 1. (Non NRT TAB CHAMPIX VARENICLINE TARTRATE ) Doses : 0.5 mg DLY x 3 /7 0.5 mg BD x 4/7 1.0 mg BD x 11/52 2. Treatment for 12 weeks Am dose - After light breakfast Or 11/2-2 hours after heavy breakfast Pm dose - 1.5 hrs. - 2 hrs. after dinner (To prevent from nausea or vomiting) NRT can take with others medication

COMMUNICATE MANAGEMENT PLAN TO THE PATIENT, CARERS AND THE COMMUNITY HEALTHCARE PROVIDERS Effective communication between the hospital, patients and their families/carers, and community healthcare providers enhances long-term adherence with prescribed therapies and lifestyle changes. Include the patient s GP and, as applicable, community pharmacists, community nurses and other outpatient services.

Adherence to Therapy Improves Survival Patients discontinuing their medicines after an MI is common, often soon after discharge. Minimise this by: Educating patients about their medicines. This is likely to improve their understanding and knowledge and thus adherence. Starting patients on secondary preventive therapies and lifestyle changes before they leave hospital. This significantly improves long-term adherence. Involving family members in educational efforts. Smoking cessation, weight loss and increased physical activity are enhanced by enlisting the support of family members. Communicating risk of future cardiovascular events.

Long-Term Management A discharge letter/summary should include: A complete list of medicines. Document why guideline medicines have not been prescribed and alternative medicine(s) used. Any changes to medicines being taken at admission. A plan for required dose titration (include who is responsible). Recommendations for monitoring and management of medicine-related adverse effects. Treatment goals including blood pressure, blood lipid levels, weight, HbA1c. Referral for cardiac rehabilitation. Advice given on lifestyle modifications (e.g. smoking cessation as applicable). Recommendations for use of dose-administration aids, carer support and referral for a Home Medicines Review.

Thank you